MedPath

Pre-meal Protein Drink Improve Glycemic Regulation

Phase 1
Terminated
Conditions
Type 2 Diabetes Mellitus
Registration Number
NCT01987674
Lead Sponsor
Lund University
Brief Summary

The purpose of this study is to investigate if a pre-meal drink containing proteins can positively influence glycaemic control in patients with type 2 diabetes mellitus. Comparison with a placebo is included.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • diagnosed type 2 diabetes mellitus according to WHO criteria (1999)
  • age between 30-80 years
  • non well controlled diabetes with HbA1c-levels above 62 mmol/mol
Exclusion Criteria
  • pregnant or risk of becoming pregnant
  • severe disease
  • psychological disease, dementia or mental disability that makes it impossible to retrieve informed consent of participation
  • liver disease
  • kidney malfunction (GFR <60 or aspartate transaminase (ASAT)/alanine transaminase (ALT) two times higher than the normal interval

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
HbA1c16 weeks

Glycated hemoglobin

Secondary Outcome Measures
NameTimeMethod
Postprandial glycemia16 weeks

Meal challenge given at start and end of study with repeated blood glucose sampling over 2h.

Trial Locations

Locations (1)

Lindsdals hälsocentral

🇸🇪

Kalmar, Sweden

Lindsdals hälsocentral
🇸🇪Kalmar, Sweden

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.